Replacing two-yearly pap smears with five-yearly testing for the human papillomavirus (HPV) is expected to reduce cervical cancer rates even further, writes Karen Canfell.
It's frustrating that patients do not or aren't able to act on results showing their genetic risk factors for cancer, argues Robyn Ward.
One in three people with newly diagnosed bowel cancer and a genetic predisposition to further cancers would still not take the necessary steps to prevent disease.
UNSW Professor David Sinclair has used a compound in red wine to develop a revolutionary class of drugs with the potential to prevent age-related illnesses and extend lifespans.
Using a super-resolution fluorescent microscope, medical scientists are a step closer to understanding why and how human immune cells decide to activate or not, thus enabling or preventing disease taking hold in the body.
Human trials have begun on a groundbreaking anti-cancer drug, developed at UNSW, with the power to shrink tumours and potentially provide an alternative to chemotherapy.
Research into the biology of brain cancer by the Children’s Cancer Institute has been recognised as one of the top 10 medical research projects in Australia.
Four of the world's best minds in brain cancer research will join UNSW's Lowy Cancer Research Centre as part of a new visiting academic program.
Scientists have found a new genetic mechanism that makes some families more susceptible to colorectal, bowel and other cancers.
Australia's Chief Scientist, Professor Ian Chubb, has launched the Australian Centre for Nanomedicine at UNSW - the first research centre of its kind in the nation.